List of SBIR/STTR awards granted to PharmaSeq, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in September, 2020 for $149,932.0 USD from the U.S. Department of Health & Human Services and Centers for Disease Control and Prevention. | SBIR | 1R43CK000576-01A1 | Phase I | 149,932 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in May, 2019 for $223,262.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM133228-01 | Phase I | 223,262 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in September, 2015 for $286,085.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HG008714-01 | Phase I | 286,085 | September 7, 2015 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in February, 2015 for $224,965.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA193087-01 | Phase I | 224,965 | February 1, 2015 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in September, 2017 for $301,203.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM123903-01 | Phase I | 301,203 | September 14, 2017 | |||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. in September, 2015 for $357,534.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HG008714-01 | Phase II | 357,534 | September 7, 2015 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. in January, 2013 for $149,989.0 USD from the National Science Foundation. | SBIR | 1248465 | Phase I | 149,989 | January 1, 2013 | |||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. in December, 2014 for $659,188.0 USD from the National Science Foundation. | SBIR | 1430956 | Phase II | 659,188 | December 1, 2014 | |||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM096580-01 | Phase I | 150,000 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $998,411.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CO140050 | Phase II | 998,411 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $2,997,640.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL074607-04A2 | Phase II | 2,997,640 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA163008-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $150,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CN0800020 | Phase I | 150,000 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL074607-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $746,326.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44RR022969-02A1 | Phase II | 746,326 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $272,360.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA168014-01A1 | Phase I | 272,360 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $117,362.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM087834-01 | Phase I | 117,362 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA110815-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $199,909.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120069 | Phase I | 199,909 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $911,270.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA163008-02 | Phase II | 911,270 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB006049-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to PharmaSeq, Inc. for $127,545.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG003264-01 | Phase I | 127,545 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $1,172,636.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM096580-02 | Phase II | 1,172,636 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $1,252,910.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA132547-03 | Phase II | 1,252,910 | ||||||||
A SBIR Phase II contract was awarded to PharmaSeq, Inc. for $1,112,310.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM087834-02 | Phase II | 1,112,310 |
